For example, the release of PDGF (platelet-derived growth factor), VEGF (vascular endothelial growth factor), uPA (urokinase plasminogen activator) and TGF-β have all been shown to increase the invasive capabilities of cancer cells in vitro [15, 42, 43]. The gene discussed is TGFB1; the disease is cancer.